lymphoma
Conditions
Sponsors
The First Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Age
14 Years to 89 Years
Inclusion criteria
Inclusion criteria: Pathologically diagnosed malignant lymphoma between January 2013 and August 2020, underwent 18F FDG PET/CT and showed diffuse increased splenic or BM uptake.
Exclusion criteria
Exclusion criteria: 1. Suffering from primary diseases of liver, spleen or bone marrow, or a history of other malignant tumors; 2. Received granulocyte colony-stimulating factor (G-CSF) therapy within 1 month before 18F FDG PET/CT examination or had other reasons that may affect liver, spleen or bone marrow metabolism (such as anemia, any infectious disease or invasive surgery, etc.); 3. Increased focal uptake in liver, spleen and bone marrow; 4. The digital image data cannot be retrospectively analyzed; 5. Lost to follow-up within 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average standard intake value;Overall survival;SEN, SPE, ACC, AUC of ROC, PPV, NPV; | — |
Countries
China
Contacts
Public ContactDeng Shengming
The First Affiliated Hospital of Soochow University
Outcome results
None listed